Specimen SS-F-AST-272 // ASTRINGENCY · IFI-A
Gallic Acid Enhancement IV-IV-B
Punica granatum
Pomegranate
Target Trait
3.65×
fold-change
Gallic acid (hydrolysable tannin precursor) accumulation
Technical Specifications
SKU
SS-F-AST-272
Genomic Edits
8
GC Content
46.2%
Construct Length
4,388 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Receptor Target
Polyphenol-astringency axis
IFI Score
365
Pathway Edits
- GAE upregulation (gallate-ester hydrolase) for galloyl group liberation
- GT1 galloylquinic acid glucosyltransferase amplification
- BAHD-GalT acyltransferase overexpression for galloyl-glucose ester formation
- 4CL (4-coumarate:CoA ligase) shikimate branch redirection
- C4H (cinnamate 4-hydroxylase) phenylpropanoid flux enhancement
- Cell-free wheat germ extract reconstitution system
- Enhanced flux via 5'UTR synthetic leader sequence optimization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Industrial ellagic acid extraction, premium pomegranate nutraceutical production, beverage polyphenol ingredient scale-up. Enhanced variant for premium or research-grade applications requiring peak astringency fidelity.
License
$4049 · Tier IV License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?